These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 25726047)

  • 1. Pancreatic ductal adenocarcinoma treatment--the past, present, and future.
    Lavu H; Yeo CJ
    Semin Oncol; 2015 Feb; 42(1):4-7. PubMed ID: 25726047
    [No Abstract]   [Full Text] [Related]  

  • 2. A historical perspective on clinical advances in pancreatic diseases.
    Rustgi AK
    Gastroenterology; 2013 Jun; 144(6):1249-51. PubMed ID: 23622134
    [No Abstract]   [Full Text] [Related]  

  • 3. Treating pancreatic cancer: more antioxidants more problems?
    Alexander MS; Cullen JJ
    Expert Rev Gastroenterol Hepatol; 2018 Sep; 12(9):849-851. PubMed ID: 29956580
    [No Abstract]   [Full Text] [Related]  

  • 4. Translational therapeutic opportunities in ductal adenocarcinoma of the pancreas.
    Hidalgo M; Von Hoff DD
    Clin Cancer Res; 2012 Aug; 18(16):4249-56. PubMed ID: 22896691
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Opportunities for translation: targeting DNA repair pathways in pancreatic cancer.
    Maginn EN; de Sousa CH; Wasan HS; Stronach EA
    Biochim Biophys Acta; 2014 Aug; 1846(1):45-54. PubMed ID: 24727386
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Emerging facets in the treatment of patients with hepatopancreaticobiliary malignancies.
    McNamara MG
    Curr Probl Cancer; 2018; 42(1):8-11. PubMed ID: 29397186
    [No Abstract]   [Full Text] [Related]  

  • 7. MicroRNAs: novel diagnostic and therapeutic tools for pancreatic ductal adenocarcinoma?
    Mardin WA; Mees ST
    Ann Surg Oncol; 2009 Nov; 16(11):3183-9. PubMed ID: 19636633
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cytogenetic, Molecular, and Translational Applications in Pancreatic Ductal Adenocarcinoma: Current Evidence and Future Concepts.
    Malla RR; Kumari S
    Crit Rev Oncog; 2019; 24(2):119-132. PubMed ID: 31679207
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MYC in pancreatic cancer: novel mechanistic insights and their translation into therapeutic strategies.
    Hessmann E; Schneider G; Ellenrieder V; Siveke JT
    Oncogene; 2016 Mar; 35(13):1609-18. PubMed ID: 26119937
    [TBL] [Abstract][Full Text] [Related]  

  • 10. What is the major prognostic factor in tumor-node-metastasis staging of pancreatic adenocarcinoma?
    Santi I; Brandt A; Hemminki K
    Ann Surg Oncol; 2011 Jan; 18(1):300-1. PubMed ID: 20589435
    [No Abstract]   [Full Text] [Related]  

  • 11. Pancreatic Cancer: A Review.
    Yabar CS; Winter JM
    Gastroenterol Clin North Am; 2016 Sep; 45(3):429-45. PubMed ID: 27546841
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Molecular landscape of pancreatic cancer: challenges and clinical implications.
    Kyrochristos ID; Ziogas DE; Glantzounis GK; Roukos DH
    Future Oncol; 2017 Dec; 13(30):2741-2744. PubMed ID: 29182377
    [No Abstract]   [Full Text] [Related]  

  • 13. Toward a better understanding of pancreatic ductal adenocarcinoma: glimmers of hope?
    Partensky C
    Pancreas; 2013 Jul; 42(5):729-39. PubMed ID: 23648843
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Translational advances and novel therapies for pancreatic ductal adenocarcinoma: hope or hype?
    Chandana S; Mahadevan D
    Expert Rev Mol Med; 2009 Nov; 11():e34. PubMed ID: 19919723
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Can we move towards personalised pancreatic cancer therapy?
    Jamieson NB; Chang DK; Grimmond SM; Biankin AV
    Expert Rev Gastroenterol Hepatol; 2014 May; 8(4):335-8. PubMed ID: 24702631
    [No Abstract]   [Full Text] [Related]  

  • 16. Pancreatic ductal carcinoma: from the bench to the bedside.
    Pezzilli R
    JOP; 2006 Sep; 7(5):508-10. PubMed ID: 16998251
    [No Abstract]   [Full Text] [Related]  

  • 17. Molecular biology of adenocarcinoma of the pancreatic duct, current state and future therapeutic avenues.
    Abbas S
    Surg Oncol; 2013 Jun; 22(2):69-76. PubMed ID: 23415924
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Integrated genomic, transcriptomic, and RNA-interference analysis of genes in somatic copy number gains in pancreatic ductal adenocarcinoma.
    Samuel N; Sayad A; Wilson G; Lemire M; Brown KR; Muthuswamy L; Hudson TJ; Moffat J
    Pancreas; 2013 Aug; 42(6):1016-26. PubMed ID: 23851435
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Molecular pathogenesis of pancreatic cancer.
    Maitra A; Kern SE; Hruban RH
    Best Pract Res Clin Gastroenterol; 2006 Apr; 20(2):211-26. PubMed ID: 16549325
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Unusual dMMR Phenotype Locally Advanced Pancreatic Ductal Adenocarcinoma with Germline and Somatic BRCA2 Mutation in a Jehovah Witness Patient.
    Copur MS; Tun SM; Vargas L; Merani S; Wedel W; Duckert R; Horn A; Lintel N; Herold D; Lavudi S
    Clin Colorectal Cancer; 2023 Mar; 22(1):160-165. PubMed ID: 36404245
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.